Nodthera
5 known investors
NodThera develops clinical-stage molecular therapies for cardiometabolic and neuroinflammatory diseases. The company focuses on inflammation-based treatments targeting cardiovascular disease, metabolic dysfunction, and neuroinflammation affecting large patient populations.